NP
IBB icon

NorthRock Partners’s iShares Biotechnology ETF IBB Stock Holding History

NorthRock Partners’s Portfolio IBB Stock Details IBB Fund Activity
Bought
Maintained
Sold
Quarter Market Value Status Shares Change in
Stake 		Trade Value Portfolio Weight Portfolio Position
2026
Q2 		$369K Buy
1,940
+662
+52% +$114K 0.01% 489
2026
Q1 		$216K Sell
1,278
-11
-0.9% -$1.88K ﹤0.01% 608
2025
Q4 		$218K Buy
+1,289
New +$209K ﹤0.01% 552
2025
Q3 		– Sell
-2,166
Closed -$274K – 889
2025
Q2 		$274K Sell
2,166
-44
-2% -$5.4K 0.01% 560
2025
Q1 		$283K Buy
2,210
+33
+2% +$4.47K 0.01% 481
2024
Q4 		$288K Sell
2,177
-119
-5% -$16.7K 0.01% 481
2024
Q3 		$334K Hold
2,296
– – 0.01% 462
2024
Q2 		$315K Sell
2,296
-50
-2% -$6.67K 0.01% 457
2024
Q1 		$322K Sell
2,346
-201
-8% -$27.4K 0.01% 462
2023
Q4 		$346K Buy
+2,547
New +$311K 0.01% 423
2022
Q2 		– Sell
-3,555
Closed -$463K – 328
2022
Q1 		$463K Sell
3,555
-443
-11% -$57.7K 0.04% 180
2021
Q4 		$610K Buy
3,998
+681
+21% +$105K 0.05% 150
2021
Q3 		$552K Sell
3,317
-130
-4% -$21.9K 0.05% 152
2021
Q2 		$564K Buy
3,447
+90
+3% +$13.9K 0.05% 128
2021
Q1 		$505K Buy
3,357
+157
+5% +$24.9K 0.05% 119
2020
Q4 		$485K Buy
+3,200
New +$457K 0.05% 130

Other funds holding IBB

Bank of America
Bank of America Charlotte, North Carolina $1.55T AUM 33.47% 1-Year Est. Return
Citigroup
Citigroup New York $303B AUM 53.02% 1-Year Est. Return
Morgan Stanley
Morgan Stanley New York $1.89T AUM 35.08% 1-Year Est. Return
BNP Paribas Financial Markets
BNP Paribas Financial Markets Paris, France $289B AUM 60.46% 1-Year Est. Return
Two Sigma Investments
Two Sigma Investments New York $138B AUM 41.87% 1-Year Est. Return
Goldman Sachs
Goldman Sachs New York $1.15T AUM 47.82% 1-Year Est. Return
Envestnet Asset Management
Envestnet Asset Management Chicago, Illinois $424B AUM 22.96% 1-Year Est. Return
Raymond James Financial
Raymond James Financial St Petersburg, Florida $369B AUM 28.27% 1-Year Est. Return
Wells Fargo
Wells Fargo San Francisco, California $617B AUM 30.33% 1-Year Est. Return
CB
Commerce Bank Kansas City, Missouri $22.8B AUM 28.56% 1-Year Est. Return

NorthRock Partners's IBB Position: Q2 2026 in Review

NorthRock Partners increased its iShares Biotechnology ETF (IBB) stake by 52% in Q2 2026, buying an estimated $114K and bringing the position to 1,940 shares worth $369K. The position accounts for 0.01% of the portfolio, ranked #489.

NorthRock Partners first reported a position in IBB in Q4 2020 and has held it in 16 quarters since. The position peaked at $610K in Q4 2021. 957 funds tracked by Wall St. Rank hold IBB as of Q2 2026.

  • NorthRock Partners held 1,940 shares of iShares Biotechnology ETF worth $369K as of Q2 2026.
  • NorthRock Partners bought 662 iShares Biotechnology ETF shares in Q2 2026, an estimated $114K.
  • iShares Biotechnology ETF made up 0.01% of NorthRock Partners's portfolio in Q2 2026, its #489 holding.
  • NorthRock Partners first reported a position in iShares Biotechnology ETF in Q4 2020 and has held it in 16 quarters since.
  • NorthRock Partners's iShares Biotechnology ETF position peaked at $610K in Q4 2021.
  • 957 funds tracked by Wall St. Rank held iShares Biotechnology ETF as of Q2 2026.

Based on NorthRock Partners's 13F filing for Q2 2026, filed 11 Aug 2026.